Guardant Health, Inc. Quarterly Costs and Expenses in USD from Q3 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Guardant Health, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2017 to Q2 2024.
  • Guardant Health, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $278M, a 8.21% increase year-over-year.
  • Guardant Health, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $1.16B, a 9.54% increase year-over-year.
  • Guardant Health, Inc. annual Costs and Expenses for 2023 was $1.13B, a 13.6% increase from 2022.
  • Guardant Health, Inc. annual Costs and Expenses for 2022 was $994M, a 26.7% increase from 2021.
  • Guardant Health, Inc. annual Costs and Expenses for 2021 was $785M, a 44.9% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.16B $278M +$21.1M +8.21% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.13B $268M +$5.41M +2.06% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.13B $353M +$79.6M +29.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $1.05B $257M -$5.43M -2.07% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $1.05B $257M +$17.3M +7.23% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $1.04B $263M +$43.3M +19.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $994M $273M +$66.7M +32.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $927M $262M +$59.9M +29.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $867M $239M +$49.7M +26.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $818M $219M +$32.9M +17.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $785M $206M +$36.8M +21.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $748M $202M +$53.2M +35.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $695M $190M +$68.8M +56.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $626M $187M +$84.1M +82.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $542M $169M +$80.6M +90.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $461M $149M +$70.5M +90% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $391M $121M +$51.7M +74.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $339M $102M +$42.1M +69.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $297M $88.9M +$28.6M +47.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $268M $78.3M +$32.4M +70.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $236M $69.2M +$27.2M +64.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $209M $60.3M +$25M +70.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $184M $60.3M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $45.9M +$6.09M +15.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $42.1M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $35.3M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $39.8M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.